Dr. Clay Siegall’s Innovative Cancer Treatment Impresses Many

Seattle Genetics is among the many companies making its way to Cancer research field. The company is focused on improving the lives of all cancer patients. The company has been in business for about a decade and seems to be rising fast and establishing their position in the field. The Seattle Genetics, state-of-the-art, was founded by Dr. Siegall in 1998 and grown as he worked steadily to improve the advancements as well as come up with innovative therapies for the patients. Currently, Dr. Siegall is the president, CEO as well as the chairman of the Seattle Genetics’ Board since 2002.

Dr. Siegall earned his Ph. In genetics from the George Washington University and started off at the Bristol-Myers Squibb Pharmaceutical Research Institute as a Senior Research Investigator. He was then promoted and made the Principal Scientist. Before long, Dr. Siegall became a Staff Fellow and Biotechnology Fellow at the National Cancer Institute after which he began to launch Seattle Genetics.

Besides all of his professional achievements, Dr. Siegall has maintained his focus on research and cause implementation of state-of-the-art developments to help cancer patients by relieving their pain. Because of his desire and motivation, Seattle Genetics developed the first antibody-drug conjugate (ADCs) such as ADCETRIS which gained approval in 2011. It is now expanding and readily available to patients in more than 60 countries worldwide.

Often, news releases find him to be hard-working and compassionate at what he does and in the process ready to help people in need. According to seattlepi.com, Dr. Siegall has made great accomplishment in the use of antibodies to save lives. As the CEO of Seattle Genetics, he works tirelessly; to come up with new, more advanced ways of combating with the illness. Additionally, he is helping in the fundraising of more than $1.2 billion for his company.

As the CEO of Seattle Genetics, Dr. Clay Siegall has to ensure that there are new advancements at all time to keep his patients alive. He steers his company to discovering better technologies and methods of dealing with cancer. Dr. Siegall is a blessing to all cancer patients as he will continue to put in his time to ensuring that cancer will eventually be under control.